The first data recorded from a pilot study on the controlled dispensing of recreational cannabis in the canton of Basel-Landschaft are now available.
This study, named the "Grashaus Projects," is one of seven approved by the Swiss Federal Office of Public Health (FOPH). The primary objective of these pilot projects is to understand the implications of regulated cannabis access. Insights derived will inform potential future cannabis regulations in Switzerland.
Under this pilot project set to last five years, cannabis stores opened in Allschwil in December with professional "budtenders". These trained socialists are educating consumers on safer use and offering information and advice on various products, including dried flowers, hashish, edibles and extracts.
Sanity Group, a German entity and the sole non-Swiss company involved in the Swiss pilot projects brings the first data.
More than 700 people enrolled in the study, which is created to include up to 4,000 consumers, writes Cannabis Health. Approximately, 80% of participants are males and around a quarter are aged between 23 and 27 years.
As part of the study, consumption behavior, and the physical and mental health of the participants are recorded. Furthermore, social impacts are also analyzed in partnership with the public prosecutor's office.
Read Also: Switzerland Launches Cannabis Study With 7.5k Participants & More Pot Updates In Europe
Favoring Lower-Risk Forms Of Consumption, Illegal Sales Decline
Among the most important findings, six months into the program is the trend toward lower-risk forms of consumption.
Around four months into the study, a decline in average flower and hashish use was noticed. Extracts, vapes, and edibles had the biggest growth. More precisely, extract sales have risen 50% since the launch. The analysis suggests that it is possible that the "targeted professional advice" caused this change in the trend.
The initial reaction to the study is positive. "Security of supply" and "product quality" were the key reasons for taking part. During these six months, more than 5,000 products including 35kg of marijuana flowers and about 4kg of hashish have been dispensed.
Another significant finding is that the proportion of parallel purchases of products from the illicit market seems to be declining in line with this.
"The fact that we have been able to record such initial successes, thanks in part to targeted professional advice in the sales outlets, is a hopeful development," said Professor Michael Schaub, scientific director of the Swiss Institute for Addiction and Health Research ISGF, guiding the study. "Because the aim of the pilot project, to make high-quality, safe products from controlled sources available to consumers and thus to minimize health risks in particular, is of course always the focus."
Schaub concluded that the idea is to destigmatize cannabis use and "create an evidence-based basis for the further legalization debate in Switzerland."
Continue reading on Cannabis Health.
Read Next:
To learn more about new cannabis laws, industry impact, social equity and everything in the space across the globe, come, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.
Photo: Courtesy of Nuva Frames via Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.